Potential Immunological Treatments in COVID-19 Patients

Potential Immunological Treatments in COVID-19 Patients

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seemed in Wuhan, China in December 2019. SARS-CoV-2 infection in human was named as coronavirus disease 2019 (COVID-19). It has now infected more than 69 million people worldwide, becoming an epidemic responsible for more than 1,5 million...

Full description

Bibliographic Details
Main Authors: Muhammet Mesut Nezir Engin, Öner Özdemir
Format: Article
Language:English
Published: Duzce University 2021-04-01
Series:Düzce Tıp Fakültesi Dergisi
Subjects:
anakinra
bamlanivimab
covid-19
konvalesan plazma
eculizumab
intravenöz immünoglobulin
itolizumab
monoklonal antikorlar
sarilumab
siltuximab
tocilizumab
svilobelimab
convalescent plasma
intravenous immunoglobulin
monoclonal antibodies
Online Access:https://dergipark.org.tr/tr/pub/dtfd/issue/60168/856165

Internet

https://dergipark.org.tr/tr/pub/dtfd/issue/60168/856165

Similar Items